Catalyst Wire Dossier Catalyst Wire Dossier

Pegylated Interferon α-2b

pegylated interferon alfa-2b
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Pegylated Interferon α-2b, covering 2011-01-12 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B [Phase 4]

See pricing